Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | pyruvate kinase, putative | 0.0032 | 0.1901 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0028 | 0.15 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0028 | 0.15 | 0.259 |
Echinococcus multilocularis | pyruvate kinase | 0.0032 | 0.1901 | 0.3513 |
Trypanosoma brucei | pyruvate kinase 1, putative | 0.0032 | 0.1901 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0061 | 0.4724 | 0.4339 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0028 | 0.15 | 0.259 |
Giardia lamblia | Pyruvate kinase | 0.0032 | 0.1901 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0028 | 0.15 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0028 | 0.15 | 0.259 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 0.4724 | 1 |
Loa Loa (eye worm) | pyruvate kinase | 0.0032 | 0.1901 | 0.131 |
Loa Loa (eye worm) | TAR-binding protein | 0.0061 | 0.4724 | 0.4339 |
Schistosoma mansoni | pyruvate kinase | 0.0032 | 0.1901 | 0.3513 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 0.4724 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0081 | 0.6638 | 0.6392 |
Echinococcus multilocularis | tar DNA binding protein | 0.0061 | 0.4724 | 1 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0032 | 0.1901 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0026 | 0.1253 | 0.2023 |
Echinococcus multilocularis | pyruvate kinase | 0.0026 | 0.124 | 0.1992 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.1253 | 0.0615 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0032 | 0.1901 | 0.5 |
Echinococcus multilocularis | GPCR, family 2 | 0.0026 | 0.1253 | 0.2023 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0036 | 0.2244 | 0.4299 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0026 | 0.1253 | 0.1253 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0032 | 0.1901 | 0.5 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0026 | 0.1253 | 0.2023 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0026 | 0.1253 | 0.1253 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0032 | 0.1901 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.1901 | 0.131 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0026 | 0.1253 | 0.2023 |
Plasmodium vivax | pyruvate kinase, putative | 0.0032 | 0.1901 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0061 | 0.4724 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0036 | 0.2244 | 0.1678 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.002 | 0.068 | 0.201 |
Schistosoma mansoni | hypothetical protein | 0.0026 | 0.1253 | 0.2023 |
Entamoeba histolytica | hypothetical protein | 0.0028 | 0.15 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0036 | 0.2244 | 0.2244 |
Leishmania major | pyruvate kinase | 0.0032 | 0.1901 | 1 |
Mycobacterium leprae | Probable pyruvate kinase PykA | 0.0032 | 0.1901 | 0.5 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0026 | 0.1253 | 0.0615 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0081 | 0.6638 | 0.6638 |
Brugia malayi | Pyruvate kinase, M2 isozyme | 0.0032 | 0.1901 | 0.1901 |
Chlamydia trachomatis | pyruvate kinase | 0.0032 | 0.1901 | 0.5 |
Brugia malayi | hypothetical protein | 0.0028 | 0.15 | 0.15 |
Toxoplasma gondii | pyruvate kinase PyK1 | 0.0032 | 0.1901 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0026 | 0.1253 | 0.2023 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 0.4724 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0036 | 0.2244 | 0.4299 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0026 | 0.1253 | 0.2023 |
Schistosoma mansoni | pyruvate kinase | 0.0032 | 0.1901 | 0.3513 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.002 | 0.068 | 0.201 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 0.4724 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 0.4724 | 1 |
Loa Loa (eye worm) | pyruvate kinase | 0.0032 | 0.1901 | 0.131 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0951 | 0.0291 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0032 | 0.1901 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0055 | 0.4146 | 0.4146 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.002 | 0.068 | 0.201 |
Plasmodium falciparum | pyruvate kinase | 0.0032 | 0.1901 | 1 |
Loa Loa (eye worm) | pyruvate kinase | 0.0032 | 0.1901 | 0.131 |
Mycobacterium tuberculosis | Probable pyruvate kinase PykA | 0.0032 | 0.1901 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0116 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.6638 | 0.6392 |
Brugia malayi | Pyruvate kinase, muscle isozyme | 0.0032 | 0.1901 | 0.1901 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0081 | 0.6638 | 0.6638 |
Loa Loa (eye worm) | pyruvate kinase-PB | 0.0023 | 0.0951 | 0.0291 |
Brugia malayi | hypothetical protein | 0.002 | 0.068 | 0.068 |
Echinococcus multilocularis | pyruvate kinase | 0.0032 | 0.1901 | 0.3513 |
Brugia malayi | TAR-binding protein | 0.0061 | 0.4724 | 0.4724 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.4146 | 0.3718 |
Trypanosoma brucei | pyruvate kinase 1 | 0.0032 | 0.1901 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0026 | 0.1253 | 0.2023 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0036 | 0.2244 | 0.4299 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0036 | 0.2244 | 0.4299 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.002 | 0.068 | 0.201 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0116 | 1 | 1 |
Leishmania major | pyruvate kinase | 0.0032 | 0.1901 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0028 | 0.15 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0028 | 0.15 | 0.259 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0036 | 0.2244 | 0.4299 |
Schistosoma mansoni | hypothetical protein | 0.0055 | 0.4146 | 0.867 |
Schistosoma mansoni | hypothetical protein | 0.0026 | 0.1253 | 0.2023 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0026 | 0.1253 | 0.2023 |
Echinococcus granulosus | pyruvate kinase | 0.0032 | 0.1901 | 0.3513 |
Echinococcus granulosus | pyruvate kinase | 0.0032 | 0.1901 | 0.3513 |
Brugia malayi | RNA binding protein | 0.0061 | 0.4724 | 0.4724 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0061 | 0.4724 | 0.4339 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0036 | 0.2244 | 0.4299 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0036 | 0.2244 | 0.4299 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0032 | 0.1901 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0061 | 0.4724 | 0.4724 |
Mycobacterium ulcerans | pyruvate kinase | 0.0032 | 0.1901 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 6.7 uM | Cytotoxicity against human HeLa cells after 72 hrs by alamar blue assay | ChEMBL. | 22954735 |
IC50 (functional) | = 20.5 uM | Cytotoxicity against human NCI-H157 cells after 72 hrs by alamar blue assay | ChEMBL. | 22954735 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 22954735 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.